Platform trials streamline ALS therapy evaluation by rapidly ruling out ineffective drugs
Massachusetts General Hospital coordinated the first four platform trials within the HEALEY ALS platform to evaluate ...
Medpage Today on MSN2d
Two Investigational Treatments for ALS Show Glimmer of Hope
The first four treatments in a platform trial for amyotrophic lateral sclerosis (ALS) failed to reach key endpoints in phase ...
News Medical on MSN1d
Study of familial ALS in Egypt reveals that genetic variations may contribute to disease progression
Amyotrophic lateral sclerosis (ALS) is a devastating neurodegenerative disease characterized by the progressive degeneration ...
News Medical on MSN2d
Groundbreaking ALS platform trial accelerates research and drug testing
Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease with few treatment options. Since 2018, the Sean M. Healey & AMG Center for ALS at Massachusetts General Hospital (MGH), a ...
Accelerated drug-testing platform for ALS paves way for therapeutic innovation
Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease with few treatment options. Since 2018, the Sean M.
Study reveals immune system's crucial role in amyotrophic lateral sclerosis at cellular level
A team of researchers from the Sant Pau Research Institute (IR Sant Pau) has published a study in the Journal of ...
Health Rounds: Gene editing may hold key to preventing Down syndrome
Gene editing techniques may one day allow for the removal of the extra chromosome that causes Down syndrome, early ...
Amylyx Pharmaceuticals (AMLX) to Release Quarterly Earnings on Thursday
Amylyx Pharmaceuticals (NASDAQ:AMLX – Get Free Report) is expected to be releasing its earnings data before the market opens ...
Investors who Lost Money on Voyager Therapeutics, Inc. Should Contact Levi & Korsinsky about an Ongoing Investigation - VYGR
NEW YORK, NY / ACCESS Newswire / February 19, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Voyager ...
Science Daily1d
New lipid nanoparticle platform delivers mRNA to the brain through the blood-brain barrier
Scientists have developed a lipid nanoparticle system capable of delivering messenger RNA (mRNA) to the brain via intravenous injection, a challenge that has long been limited by the protective nature ...